• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Guillain-Barr? Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009

tetano

Editor, Senior Moderator
Emerg Infect Dis. 2013 Dec;19(12):1956-62. doi: 10.3201/eid1912.130643.
Guillain-Barr? Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009.
Giambrone GP, Zansky SM, Eidson M, Duncan PG, McNutt LA, Birkhead GS.
Abstract

The New York State Department of Health (NYSDOH) collected information about hospitalized patients with Guillain-Barr? syndrome (GBS) during October 2009-May 2010, statewide (excluding New York City), to examine a possible relationship with influenza A(H1N1)pdm09 vaccination. NYSDOH established a Clinical Network of neurologists and 150 hospital neurology units. Hospital discharge data from the Statewide Planning and Research Cooperative System (SPARCS) were used to evaluate completeness of reporting from the Clinical Network. A total of 140 confirmed or probable GBS cases were identified: 81 (58%) from both systems, 10 (7%) from Clinical Network only, and 49 (35%) from SPARCS-only. Capture-recapture methods estimated that 6 cases might have been missed by both systems. Clinical Network median reporting time was 12 days versus 131 days for SPARCS. In public health emergencies in New York State, a Clinical Network may provide timely data, but in our study such data were less complete than traditional hospital discharge data.
KEYWORDS:

GBS, Guillain-Barr? syndrome, New York, influenza A(H1N1) 2009 monovalent vaccine, pandemic H1N1 2009 influenza virus, vaccination campaign, viruses

PMID:
24274387
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24274387
 
Back
Top Bottom